- Record: found
- Abstract: found
- Poster: found
Drug Development and Discovery (D3)
Abstract
Abstract
Background and Objectives: In drug research and development whereby, the patient is the main focus, the mission is to overcome the disease and improve the quality of life. The process is designed to ensure that the newly produced medicines are SAFE, EFFECTIVE, and available for the patient in a brief period. As per FDA, drug development and discovery involve five main steps: discovery and development, preclinical research, clinical research, FDA review, and FDA post-market safety and monitoring.
With several disease outbreaks, drug discovery, and development has been essential tool in saving lives and ensuring the standard health status. Through research, it brings new drugs into the market against targeted diseases. With the aim of D3, the drugs are assessed under surveillance and monitoring to ensure their safety and efficacy.
Methods: Several methods have been generated to develop drugs in a brief period. Following the FDA process of drug development and discovery, a technological method is set per each step, these include computerized methods like High-throughput screening and Computer-based design used in designing a drug hit candidate and the use of pharmacological software to study the mechanism of action of the disease as well as the effectiveness and metabolism of the drug.
Results: Different studies show that research and development of drugs through drug discovery has been an essential tool in ensuring a better quality of life. It helps us understand the health condition allowing us to design drugs for newly occurring diseases and even previously untreatable conditions.
Conclusion: To play a vital role in saving lives and ensuring the best health status, it is important to understand the process of D3. FDA uses the data provided in the process to decide on different complications found in both prescribed and OTC drugs, hence controlling the serious adverse effects. This improves the process functioning as well as raises the quality of research and development.
Content
Author and article information
References
Singh Natesh, Vayer Philippe, Tanwar Shivalika, Poyet Jean-Luc, Tsaioun Katya, Villoutreix Bruno O.. Drug discovery and development: introduction to the general public and patient groups. Frontiers in Drug Discovery. Vol. 3:2023. Frontiers Media SA. [Cross Ref]